Amphastar Pharmaceuticals (AMPH) Stock Trades Up, Here Is Why [Yahoo! Finance]
Amphastar Pharmaceuticals (AMPH) Jumps 6.5% After Q3 Beat and Conference Reveal—Has the Investment Case Shifted? [Yahoo! Finance]
A Look at Amphastar Pharmaceuticals (AMPH) Valuation Following Strong Quarterly Results and Pipeline Progress [Yahoo! Finance]
Amphastar Pharmaceuticals (NASDAQ:AMPH) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Why Amphastar Pharmaceuticals (AMPH) Is Up 8.4% After Strong Q3 Revenue and Key FDA Approvals [Yahoo! Finance]